The AD-RIDDLE project is pleased to announce the soft launch of three Digital Engagement Platform (DEP) sites in Sweden for the FINGERS Brain Health Institute (FBHI), the Swedish BioFINDER study (BioFINDER) and the REAL-AD study (REAL AD). The DEP platforms have been developed by Gates Ventures in collaboration with leading Alzheimer’s and brain health research

Public Involvement What is Public Involvement and why it is important?Public Involvement (PI) is about involving members of the public (e.g., people living with the condition, their family, carers/ supporters and people with a keen interest in brain health) to varying degrees in research. It is about carrying out research and developing policies with or

YouTube video by AD-RIDDLE

YouTube video by AD-RIDDLE

On 9–10 July, the AD-RIDDLE consortium gathered in Barcelona, Spain, for its third General Assembly Meeting, hosted by the Barcelonaβeta Brain Researc

The AD-RIDDLE project is pleased to announce the soft launch of three Digital Engagement Platform (DEP) sites in Sweden for the FINGERS Brain Health I

YouTube video by Alzheimer Europe

YouTube video by AD-RIDDLE

INTRODUCTION We assessed the accuracy of the Amsterdam Instrumental Activities of Daily Living Questionnaire (A-IADL-Q) for clinical staging in Swedish primary care. METHODS Participants from the ...

Ghent, Belgium and Tokyo, Japan, May 11, 2026 - H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

The AD-RIDDLE project has reached an important milestone: the recruitment target for its pilot study on digital cognitive assessments (DCAs) has been

The AD-RIDDLE project invites healthcare professionals involved in Alzheimer’s care or diagnosis to participate in a short online survey exploring the

Artificial Intelligence is playing an increasingly important role in innovation in health research and healthcare, from prevention and early detection to diagnosis, treatment and long-term disease man...

PROMINENT and AD-RIDDLE, two projects focusing on Alzheimer’s disease, are channelling health economics to ensure that new therapies and diagnostic methods for Alzheimer’s disease can be effectively implemented.